The NFL has confirmed that a team of independent medical experts will conduct a formal review into the circumstances surrounding
The 28-year-old
Details of the Medical Review and League Protocols
Jeff Miller, the NFL’s executive vice president of communications, public affairs, and health policy, addressed the matter in a statement released by Senator Blunt Rochester’s office. Miller explained that the review will be conducted by mutually agreed-upon experts, as outlined in the Collective Bargaining Agreement. While the specific parameters of the investigation are still being finalized, the findings will be used to determine if additional league-wide guidance is necessary regarding clotting disorders.
The league also highlighted its existing medical infrastructure, noting that it has tracked clotting disorders among players for over a decade through a subcommittee of the General Medical Committee. This data is regularly shared with the NFLPA. Although the union has not formally invoked Article 39 of the CBA—which would trigger a specific investigation into club-affiliated medical care—the current joint review will utilize similar guidelines. Under these provisions, neutral physicians are required to submit a written report within 60 days of their appointment, with both the league and the union expected to act on any resulting recommendations.
Current Status of Hurts' Recovery
Following the initial discovery, a joint statement from the Eagles and Hurts' agent, Nicole Lynn, confirmed that the quarterback was diagnosed with deep vein thrombosis and bilateral pulmonary emboli. While he is reported to be clinically stable with no significant functional limitations, his treatment plan requires the use of anticoagulants. These blood-thinning medications strictly prohibit participation in contact sports, effectively ruling him out for the rest of the season.
Senator Blunt Rochester, who initiated the correspondence with NFL Commissioner Roger Goodell in October, expressed appreciation for the league's transparency. In his response, Miller indicated that the NFL is open to further collaboration, stating that the league welcomes the opportunity to support efforts in raising awareness and improving health outcomes related to blood clot disorders.
